Blog

As Compliance Officers, your role includes cultivating strong, effective relationships with your health center’s leadership—most critically, the board of directors and its compliance oversight committee. The board sets the “tone from the [...]

Key Challenges Still Loom for Covered Entities On Monday, May 12, the White House issued an Executive Order (EO) aimed at addressing  prescription drug prices. The EO opens with a remarkable [...]

“Eternal vigilance is the price of liberty.”  – quote attributed to Thomas Jefferson and John Philpot Curran Over the past two years, nearly three dozen states have considered legislation requiring drug manufacturers [...]

The torrent of executive orders, policy announcements, and lawsuits during the first weeks of the Trump administration have created substantial uncertainty for community health centers (CHCs) and other non-profit organizations as they [...]

The Trump administration announced various executive orders and actions, including attempts to eliminate, pause and limit grant funding that impacted multiple sectors, including education, healthcare, and social services. In the face of [...]

This article was updated on Wednesday, February 12, 2025, at 10:50 a.m. CAP Purports to Apply to All Current and Future NIH Grants The Trump Administration’s recent efforts to apply stricter controls [...]

As a new Congress and Administration begin a dizzying series of initiatives, health centers and others participating in the federal 340B drug discount statute understandably crave predictions regarding 340B’s future. Not only [...]

New Administrative False Claims Act, Buried within the NDAA, Gives Agencies Heightened Authority to Pursue False Claims and Statements Enforcement of civil fraud at the agency level received an under-the-radar boost at [...]

On December 18, 2024, the Health Resources and Services Administration (HRSA) issued new instructions to apply for initial designation as a “look-alike” health center. There are several significant changes, both in terms [...]

Federally qualified health centers (FQHCs) and other federal grantees participating in the federal 340B drug discount statute face potentially devastating, practical effects on their ability to serve vulnerable patient populations from a [...]